Dietary xylo-oligosaccharide ameliorates colonic mucus microbiota penetration with restored autophagy in interleukin-10 gene-deficient mice.
Zhongxia ChenXiao ShenQunyan ZhouQiang ZhanXingwen XuQiuyu ChenFangmei AnJing SunPublished in: JPEN. Journal of parenteral and enteral nutrition (2021)
Therefore, XOS decreases colonic mucus microbiota penetration with restored function of antophagy. Our findings suggest that XOS may be a potential dietary supplement or functional food for early management of IBD.